QuVa Pharma Recalls Fentanyl PCA Vials Due to Glass Particulate Matter
QuVa Pharma is recalling specific lots of fentanyl PCA vials due to the potential presence of glass particulate matter.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the risk of glass particulate matter in an injectable medication.
Plain-English summary
QuVa Pharma, Inc. is recalling fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL PCA Vials, Preservative Free. The recall is being conducted because of the presence of particulate matter, specifically due to the potential for glass particles in the product.
The affected product is identified by NDC 70092-1180-79. The recall covers specific lots with expiration dates ranging from November 2019 to December 2019. The distribution pattern for these products was nationwide.
Healthcare providers and patients should check their inventory and medication supplies for the specific lot numbers listed in the recall notice. If the product is found, it should be discontinued and returned to the manufacturer or disposed of according to local regulations.
The recalled product
- Product
- fentaNYL 1500 mcg/30 mL (50 mcg/mL) 30 mL PCA Vial Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1180-79
- Manufacturer
- QuVa Pharma, Inc.
- Category
- Drug — Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lots: 10030060 Exp. 11/21/2019
- 10030574 Exp. 11/28/2019
- 10031353 Exp. 12/12/2019
- 10031677 Exp. 12/20/2019
- 10031622 Exp. 12/19/2019
- 10031419 Exp. 12/15/2019
- 10031769 Exp. 12/26/2019
- 10031826 Exp. 12/23/2019
- 10032287 Exp. 12/30/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 27 recalled by QuVa Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 27 products in this recall →Related recalls
Same manufacturer · QuVa Pharma, Inc.
See all →- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- HighCompounded pain injection syringes recalled over presence of particulate matter
FDA (Drugs) · 2025-11-05
- HighCompounded Fentanyl and Bupivacaine Epidural Injections Recalled for Sterility Assurance
FDA (Drugs) · 2025-04-02
- HighCompounded Fentanyl-Bupivacaine Epidural Injections Recalled for Sterility Failure
FDA (Drugs) · 2025-04-02
- HighCompounded Fentanyl-Ropivacaine Epidural Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2025-04-02
Same hazard · glass particulate
See all →- SevereTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighProgesterone Injection Recalled for Glass Particulate Matter in Vials
FDA (Drugs) · 2024-08-07
- HighCyanocobalamin Injection Vials Recalled for Glass Particulate Contamination
FDA (Drugs) · 2024-07-24
- HighEye and Ear Dropper Recalled for Potential Glass Particulate Contamination
FDA (Devices) · 2023-06-21